Telomerase Inhibition by MST-312 Sensitizes Breast Cancer Cells to the Anti-cancer Properties of Plumbagin
These videos have been matched automatically. Contact us if they are not relevant.
These videos have been matched automatically. Contact us if they are not relevant.
View abstract on PubMed
Summary
This summary is machine-generated.Combining plumbagin and MST-312 shows synergistic effects against breast cancer cells. This combination induces DNA damage and telomere dysfunction, leading to cell death, offering a promising therapeutic strategy.
Area Of Science
- Oncology
- Pharmacology
- Biochemistry
Background
- Breast cancer, a prevalent malignancy, comprises diverse subtypes including ER/PR-positive, HER2-amplified, and triple-negative breast cancers (TNBC).
- Phytochemicals, like plumbagin, exhibit anti-cancer properties with low cytotoxicity to normal cells.
- Telomerase reactivation in cancer cells promotes survival by preventing apoptosis.
Purpose Of The Study
- To investigate the synergistic anti-cancer effects of plumbagin and the telomerase inhibitor MST-312 in breast cancer cell lines.
- To evaluate the combinational treatment's efficacy in inducing lethality and genotoxicity.
Main Methods
- Utilized a combinatorial approach combining plumbagin (genotoxicity inducer) and MST-312 (telomerase inhibitor).
- Tested the treatment on MDA-MB-231 (TNBC) and MCF-7 (luminal) breast cancer cells.
- Assessed short-term (48h) and long-term (14-day) treatment responses and recoverability.
Main Results
- Combination treatment showed synergistic lethality in MDA-MB-231 cells across both short-term and long-term regimens.
- MCF-7 cells responded more effectively to the long-term combination treatment.
- Cytotoxic effects of the plumbagin and MST-312 combination were irreversible after short-term exposure.
Conclusions
- Combination therapy with MST-312 and plumbagin is more effective than plumbagin alone in breast cancer treatment.
- The combination induces significant DNA damage and telomere dysfunction, enhancing genome instability.
- This approach leads to cell cycle arrest and eventual cancer cell death.
These videos have been matched automatically. Contact us if they are not relevant.
These videos have been matched automatically. Contact us if they are not relevant.
Related Concept Videos
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
Microtubules are dynamic structures and can be regulated by microtubule targeting agents (MTAs). Microtubule destabilizing drugs are a class of MTAs that destabilize and prevent microtubules' polymerization. Both natural and synthetic chemicals can be found under this class of drugs. Vincristine and vinblastine, two vinca alkaloids, and colchicine were among the first to be discovered. These drugs can affect cells in various ways, either by inducing a change in cell morphology, preventing...
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...